Published in World J Gastroenterol on April 14, 2011
Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registry. J Gastroenterol (2011) 0.83
Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease. World J Gastroenterol (2014) 0.75
Inflammatory bowel disease. N Engl J Med (2002) 21.17
Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ (1989) 4.13
The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology (2001) 3.60
Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut (1994) 2.06
Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci (2004) 1.92
Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis. Dig Liver Dis (2004) 1.62
Clinical effectiveness of selective granulocyte, monocyte adsorptive apheresis with the Adacolumn device in ulcerative colitis. Dig Dis Sci (2009) 1.57
A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis. Gastroenterology (2008) 1.53
Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study. Eur J Gastroenterol Hepatol (2008) 1.50
Leukocytapheresis is effective in inducing but not in maintaining remission in ulcerative colitis. J Clin Gastroenterol (2005) 1.45
Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis. Dig Liver Dis (2006) 1.42
Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis. Inflamm Bowel Dis (2004) 1.29
Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol (2003) 1.18
Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease. Ann Pharmacother (2007) 1.10
Efficacy and safety of repeated infliximab infusions for Crohn's disease: 1-year clinical experience. Inflamm Bowel Dis (2001) 0.91
Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis. World J Gastroenterol (2006) 0.90
Leukocytapheresis as promising therapy for inflammatory bowel disease. Dig Liver Dis (2007) 0.87
Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis. World J Gastroenterol (2005) 0.87
Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis. World J Gastroenterol (2006) 0.87
Preliminary data on the use of apheresis in inflammatory bowel disease. Inflamm Bowel Dis (2006) 0.86
Granulocyte adsorptive apheresis for pediatric patients with ulcerative colitis. Dig Dis Sci (2003) 0.85
Quality of life in inflammatory bowel disease. Ital J Gastroenterol (1996) 0.84
Leucocytapheresis for inflammatory bowel disease in the era of biologic therapy. Eur J Gastroenterol Hepatol (2008) 0.81
Predictive factors of efficacy of leukocytapheresis for steroid-resistant ulcerative colitis patients. Dig Liver Dis (2007) 0.81
Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patients. J Gastroenterol (2006) 0.79
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol (2005) 10.16
Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonist. Inflamm Bowel Dis (2007) 1.46
Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol (2011) 1.36
Complete response for advanced liver cancer during sorafenib therapy: case report. BMC Gastroenterol (2011) 1.30
Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci (2002) 1.28
MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology (2005) 1.23
Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy. J Clin Virol (2008) 1.13
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis (2002) 1.12
Immunomodulatory drugs in Crohn's disease patients with hepatitis B or C virus infection. Gastroenterology (2002) 1.09
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: a prospective cohort study. Eur J Radiol (2011) 1.09
A new oral delivery system for 5-ASA: preliminary clinical findings for MMx. Inflamm Bowel Dis (2005) 1.03
Small intestine contrast ultrasonography: an alternative to radiology in the assessment of small bowel disease. Inflamm Bowel Dis (2005) 1.03
Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence. Clin Chem Lab Med (2004) 1.02
Hydrogen breath test for diagnosis of lactose malabsorption: the importance of timing and the number of breath samples. Can J Gastroenterol (2006) 0.89
99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease. Eur J Nucl Med Mol Imaging (2003) 0.89
Internet use among inflammatory bowel disease patients: an Italian multicenter survey. Eur J Gastroenterol Hepatol (2009) 0.88
Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: a cohort study. World J Gastroenterol (2009) 0.87
Primary clarithromycin resistance in Helicobacter pylori: the Multicentric Italian Clarithromycin Resistance Observational (MICRO) study. J Gastrointestin Liver Dis (2011) 0.86
Monthly and seasonal birth patterns and the occurrence of Crohn's disease. Am J Gastroenterol (2009) 0.84
Self-reported milk intolerance in irritable bowel syndrome: what should we believe? Clin Nutr (2004) 0.84
Current management of severe ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol (2007) 0.84
Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational study. J Crohns Colitis (2013) 0.84
Ferritin as a simple indicator of iron deficiency in anemic IBD patients. Inflamm Bowel Dis (2006) 0.83
Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception. Inflamm Bowel Dis (2008) 0.82
Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders. Expert Rev Gastroenterol Hepatol (2014) 0.81
Assessment of response to sorafenib in advanced hepatocellular carcinoma using perfusion computed tomography: results of a pilot study. Dig Liver Dis (2013) 0.81
Leukocytapheresis in the treatment of inflammatory bowel disease: Current position and perspectives. Transfus Apher Sci (2010) 0.81
GI distension in severe ulcerative colitis. Am J Gastroenterol (2002) 0.81
In favour of early surgery in Crohn's disease: a hypothesis to be tested. J Crohns Colitis (2010) 0.81
Video capsule endoscopy for evaluating obscure gastrointestinal bleeding and suspected small-bowel pathology. J Gastroenterol (2004) 0.80
Natalizumab in the treatment of Crohn's disease. Biologics (2008) 0.80
Biological agents for ulcerative colitis: hypes and hopes. Med Res Rev (2008) 0.80
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA database. Int J Biol Markers (2015) 0.80
Therapeutic landscape for ulcerative colitis: where is the Adacolumn(®) system and where should it be? Clin Exp Gastroenterol (2013) 0.80
The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study. J Clin Apher (2011) 0.80
Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related Symptoms. Digestion (2015) 0.80
Smad3 knock-out mice as a useful model to study intestinal fibrogenesis. World J Gastroenterol (2006) 0.79
IL-1beta-511 and IL-1RN*2 polymorphisms in inflammatory bowel disease: An Italian population study and meta-analysis of European studies. Dig Liver Dis (2009) 0.79
Medical therapy for Crohn's disease: top-down or step-up? Dig Dis (2007) 0.79
Hydrogen breath test for the diagnosis of lactose intolerance, is the routine sugar load the best one? World J Gastroenterol (2008) 0.78
Entecavir for hepatitis B virus flare treatment in patients with Crohn's disease. Hepatogastroenterology (2010) 0.78
Inflammatory bowel diseases: clinical update of practical guidelines. Nucl Med Commun (2005) 0.78
Guillain-Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: case report and literature review. J Crohns Colitis (2011) 0.77
Mesenteric adenitis caused by Yersinia pseudotubercolosis in a patient subsequently diagnosed with Crohn's disease of the terminal ileum. World J Gastroenterol (2006) 0.77
Late-breaking news from the "4th International Meeting on Inflammatory Bowel Diseases" Capri, 2006. Inflamm Bowel Dis (2007) 0.76
Long-term results of sorafenib in advanced-stage hepatocellular carcinoma: what can we learn from routine clinical practice? Expert Rev Anticancer Ther (2012) 0.76
Clinical course of late-onset Crohn's disease. Inflamm Bowel Dis (2009) 0.75
Development of fistulae in ileo-anal pouch does not necessarily indicate Crohn's disease. Am J Gastroenterol (2004) 0.75
Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases. Inflamm Bowel Dis (2007) 0.75
Partial Response and Cardiovascular Recovery after Sorafenib Dose Reduction in a Multinodular HCC Patient. J Gastrointest Cancer (2012) 0.75
Postoperative recurrence of Crohn's disease and videocapsule endoscopy: it is necessary to leave no stone unturned. Inflamm Bowel Dis (2008) 0.75
The Role on Endoscopy in Alcohol-Related Diseases. Rev Recent Clin Trials (2016) 0.75
[Predictors of clinical response in patients with ulcerative colitis treated with granulocyte-monocyte apheresis: analysis of the apheresis registry data]. G Ital Nefrol (2012) 0.75
Perianal fistulas mimicking Crohn's disease in HIV-infected male patient. Am J Gastroenterol (2009) 0.75
[Multimodal treatment for acute antibody-mediated renal transplant rejection: successful rescue therapy with combined plasmapheresis, photopheresis and intravenous immunoglobulin]. G Ital Nefrol (2012) 0.75
An unusual case of anorectal carcinoma in a patient with Crohn's disease. J Crohns Colitis (2010) 0.75
Ulcerative colitis and granulocyte-monocyte-apheresis: safety and efficacy of maintenance therapy during pregnancy. J Clin Apher (2014) 0.75